PubMed:10380915
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 45-49 | protein | denotes | JAK3 |
| T2 | 49-58 | protein | denotes | /STAT5a/b |
| T3 | 133-140 | cell_type | denotes | T cells |
| T4 | 142-163 | protein | denotes | Janus kinase 3 (JAK3) |
| T5 | 169-196 | protein | denotes | cytoplasmic tyrosine kinase |
| T6 | 210-216 | cell_type | denotes | T cell |
| T7 | 246-255 | protein | denotes | cytokines |
| T8 | 273-332 | protein | denotes | interleukin-2 (IL-2) receptor common gamma chain (gamma(c)) |
| T9 | 358-362 | protein | denotes | JAK3 |
| T10 | 483-487 | protein | denotes | JAK3 |
| T11 | 658-662 | protein | denotes | JAK3 |
| T12 | 711-780 | protein | denotes | signal transducer and activator of transcription 5a and 5b (STAT5a/b) |
| T13 | 834-843 | protein | denotes | cytokines |
| T14 | 853-861 | protein | denotes | gamma(c) |
| T15 | 885-889 | protein | denotes | IL-2 |
| T16 | 929-936 | cell_type | denotes | T cells |
| T17 | 1151-1156 | protein | denotes | Zap70 |
| T18 | 1160-1166 | protein | denotes | p56Lck |
| T19 | 1173-1181 | protein | denotes | anti-CD3 |
| T20 | 1203-1210 | cell_type | denotes | T cells |
| T21 | 1276-1280 | protein | denotes | JAK3 |
| T22 | 1328-1334 | cell_type | denotes | T cell |
| T23 | 1407-1413 | cell_type | denotes | T cell |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-141 | Sentence | denotes | Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells. |
| S2 | 142-333 | Sentence | denotes | Janus kinase 3 (JAK3) is a cytoplasmic tyrosine kinase required for T cell development and activated by cytokines that utilize the interleukin-2 (IL-2) receptor common gamma chain (gamma(c)). |
| S3 | 334-447 | Sentence | denotes | Genetic inactivation of JAK3 is manifested as severe combined immunodeficiency disease (SCID) in humans and mice. |
| S4 | 448-569 | Sentence | denotes | These findings have suggested that JAK3 represents a pharmacological target to control certain lymphoid-derived diseases. |
| S5 | 570-781 | Sentence | denotes | Here we provide novel evidence that AG-490 potently inhibits the autokinase activity of JAK3 and tyrosine phosphorylation and DNA binding of signal transducer and activator of transcription 5a and 5b (STAT5a/b). |
| S6 | 782-862 | Sentence | denotes | Similar inhibitory effects were observed with other cytokines that use gamma(c). |
| S7 | 863-994 | Sentence | denotes | AG-490 also inhibited IL-2-mediated proliferative growth in human T cells with an IC50) = 25 microM that was partially recoverable. |
| S8 | 995-1211 | Sentence | denotes | Moreover, we demonstrate that this inhibitor prevented tetanus toxoid antigen-specific T cell proliferation and expansion but failed to block activation of Zap70 or p56Lck after anti-CD3 stimulation of human T cells. |
| S9 | 1212-1503 | Sentence | denotes | Taken together, these findings suggest that AG-490 inhibits the JAK3-mediated Type II signaling pathway but not the T cell receptor-derived Type I pathway and possesses therapeutic potential for T cell-derived pathologies such as graft-versus-host disease, allergy, and autoimmune disorders. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-17 | NP | denotes | Tyrphostin AG-490 |
| C2 | 142-163 | NP | denotes | Janus kinase 3 (JAK3) |
| C3 | 246-255 | NP | denotes | cytokines |
| C4 | 256-260 | NP | denotes | that |
| C5 | 269-332 | NP | denotes | the interleukin-2 (IL-2) receptor common gamma chain (gamma(c)) |
| C6 | 358-362 | NP | denotes | JAK3 |
| C7 | 483-487 | NP | denotes | JAK3 |
| C8 | 586-600 | NP | denotes | novel evidence |
| C9 | 601-605 | NP | denotes | that |
| C10 | 606-612 | NP | denotes | AG-490 |
| C11 | 658-662 | NP | denotes | JAK3 |
| C12 | 828-843 | NP | denotes | other cytokines |
| C13 | 844-848 | NP | denotes | that |
| C14 | 853-861 | NP | denotes | gamma(c) |
| C15 | 863-869 | NP | denotes | AG-490 |
| C16 | 923-936 | NP | denotes | human T cells |
| C17 | 942-962 | NP | denotes | an IC50) = 25 microM |
| C18 | 963-967 | NP | denotes | that |
| C19 | 1025-1039 | NP | denotes | this inhibitor |
| C20 | 1197-1210 | NP | denotes | human T cells |
| C21 | 1256-1262 | NP | denotes | AG-490 |
| R1 | C4 | C3 | coref-relat | that,cytokines |
| R2 | C6 | C2 | coref-ident | JAK3,Janus kinase 3 (JAK3) |
| R3 | C7 | C6 | coref-ident | JAK3,JAK3 |
| R4 | C9 | C8 | coref-relat | that,novel evidence |
| R5 | C10 | C1 | coref-ident | AG-490,Tyrphostin AG-490 |
| R6 | C11 | C7 | coref-ident | JAK3,JAK3 |
| R7 | C13 | C12 | coref-relat | that,other cytokines |
| R8 | C14 | C5 | coref-ident | gamma(c),the interleukin-2 (IL-2) receptor common gamma chain (gamma(c)) |
| R9 | C15 | C10 | coref-ident | AG-490,AG-490 |
| R10 | C18 | C17 | coref-relat | that,an IC50) = 25 microM |
| R11 | C19 | C15 | coref-ident | this inhibitor,AG-490 |
| R12 | C20 | C16 | coref-ident | human T cells,human T cells |
| R13 | C21 | C19 | coref-ident | AG-490,this inhibitor |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-10 | other_artificial_source | denotes | Tyrphostin |
| T2 | 11-17 | other_artificial_source | denotes | AG-490 |
| T3 | 27-44 | other_name | denotes | cytokine-mediated |
| T4 | 45-49 | protein_molecule | denotes | JAK3 |
| T5 | 49-58 | protein_family_or_group | denotes | /STAT5a/b |
| T6 | 83-105 | other_name | denotes | cellular proliferation |
| T7 | 109-132 | other_name | denotes | antigen-activated human |
| T8 | 133-140 | cell_type | denotes | T cells |
| T9 | 142-158 | protein_molecule | denotes | Janus kinase 3 ( |
| T10 | 158-162 | protein_molecule | denotes | JAK3 |
| T11 | 169-196 | protein_family_or_group | denotes | cytoplasmic tyrosine kinase |
| T12 | 210-216 | cell_type | denotes | T cell |
| T13 | 246-255 | protein_family_or_group | denotes | cytokines |
| T14 | 273-293 | protein_molecule | denotes | interleukin-2 (IL-2) |
| T15 | 323-331 | protein_subunit | denotes | gamma(c) |
| T16 | 358-362 | protein_molecule | denotes | JAK3 |
| T17 | 380-427 | other_name | denotes | severe combined immunodeficiency disease (SCID) |
| T18 | 431-437 | multi_cell | denotes | humans |
| T19 | 442-446 | multi_cell | denotes | mice |
| T20 | 483-487 | protein_molecule | denotes | JAK3 |
| T21 | 543-568 | other_name | denotes | lymphoid-derived diseases |
| T22 | 606-612 | other_artificial_source | denotes | AG-490 |
| T23 | 635-654 | other_name | denotes | autokinase activity |
| T24 | 658-662 | protein_molecule | denotes | JAK3 |
| T25 | 667-691 | other_name | denotes | tyrosine phosphorylation |
| T26 | 696-707 | other_name | denotes | DNA binding |
| T27 | 711-771 | protein_family_or_group | denotes | signal transducer and activator of transcription 5a and 5b ( |
| T28 | 771-779 | protein_family_or_group | denotes | STAT5a/b |
| T29 | 834-843 | protein_family_or_group | denotes | cytokines |
| T30 | 853-861 | protein_subunit | denotes | gamma(c) |
| T31 | 863-869 | other_artificial_source | denotes | AG-490 |
| T32 | 885-889 | protein_molecule | denotes | IL-2 |
| T33 | 929-936 | cell_type | denotes | T cells |
| T34 | 945-962 | other_name | denotes | IC50) = 25 microM |
| T35 | 1151-1156 | protein_molecule | denotes | Zap70 |
| T36 | 1160-1166 | protein_molecule | denotes | p56Lck |
| T37 | 1173-1181 | protein_molecule | denotes | anti-CD3 |
| T38 | 1203-1210 | cell_type | denotes | T cells |
| T39 | 1256-1262 | other_artificial_source | denotes | AG-490 |
| T40 | 1276-1280 | protein_molecule | denotes | JAK3 |
| T41 | 1328-1334 | cell_type | denotes | T cell |
| T42 | 1407-1413 | cell_type | denotes | T cell |
| T43 | 1442-1467 | other_name | denotes | graft-versus-host disease |
| T44 | 1469-1476 | other_name | denotes | allergy |
| T45 | 1482-1502 | other_name | denotes | autoimmune disorders |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 380-412 | HP_0004430 | denotes | severe combined immunodeficiency |
| T2 | 387-412 | HP_0005387 | denotes | combined immunodeficiency |
| T3 | 396-412 | HP_0002721 | denotes | immunodeficiency |
| T4 | 1469-1476 | HP_0012393 | denotes | allergy |
| T5 | 1482-1492 | HP_0002960 | denotes | autoimmune |
| T6 | 1482-1502 | HP_0002960 | denotes | autoimmune disorders |